Literature DB >> 31308554

Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9.

Gigi C G Choi1, Peng Zhou1, Chaya T L Yuen1, Becky K C Chan1, Feng Xu1, Siyu Bao2, Hoi Yee Chu2, Dawn Thean1, Kaeling Tan3,4, Koon Ho Wong3,5, Zongli Zheng2,6,7, Alan S L Wong8,9.   

Abstract

The combined effect of multiple mutations on protein function is hard to predict; thus, the ability to functionally assess a vast number of protein sequence variants would be practically useful for protein engineering. Here we present a high-throughput platform that enables scalable assembly and parallel characterization of barcoded protein variants with combinatorial modifications. We demonstrate this platform, which we name CombiSEAL, by systematically characterizing a library of 948 combination mutants of the widely used Streptococcus pyogenes Cas9 (SpCas9) nuclease to optimize its genome-editing activity in human cells. The ease with which the editing activities of the pool of SpCas9 variants can be assessed at multiple on- and off-target sites accelerates the identification of optimized variants and facilitates the study of mutational epistasis. We successfully identify Opti-SpCas9, which possesses enhanced editing specificity without sacrificing potency and broad targeting range. This platform is broadly applicable for engineering proteins through combinatorial modifications en masse.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31308554     DOI: 10.1038/s41592-019-0473-0

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  6 in total

1.  Recent advances of genome editing and related technologies in China.

Authors:  Wen Sun; Haoyi Wang
Journal:  Gene Ther       Date:  2020-08-03       Impact factor: 5.250

2.  Rationally engineered Staphylococcus aureus Cas9 nucleases with high genome-wide specificity.

Authors:  Yuanyan Tan; Athena H Y Chu; Siyu Bao; Duc Anh Hoang; Firaol Tamiru Kebede; Wenjun Xiong; Mingfang Ji; Jiahai Shi; Zongli Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

3.  Extensible combinatorial CRISPR screening in mammalian cells.

Authors:  Peng Zhou; Yuk Kei Wan; Becky K C Chan; Gigi C G Choi; Alan S L Wong
Journal:  STAR Protoc       Date:  2021-01-09

4.  Machine learning-coupled combinatorial mutagenesis enables resource-efficient engineering of CRISPR-Cas9 genome editor activities.

Authors:  Dawn G L Thean; Hoi Yee Chu; John H C Fong; Becky K C Chan; Peng Zhou; Cynthia C S Kwok; Yee Man Chan; Silvia Y L Mak; Gigi C G Choi; Joshua W K Ho; Zongli Zheng; Alan S L Wong
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

5.  Suppression of unwanted CRISPR-Cas9 editing by co-administration of catalytically inactivating truncated guide RNAs.

Authors:  John C Rose; Nicholas A Popp; Christopher D Richardson; Jason J Stephany; Julie Mathieu; Cindy T Wei; Jacob E Corn; Dustin J Maly; Douglas M Fowler
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

6.  High-fidelity KKH variant of Staphylococcus aureus Cas9 nucleases with improved base mismatch discrimination.

Authors:  Chaya T L Yuen; Dawn G L Thean; Becky K C Chan; Peng Zhou; Cynthia C S Kwok; Hoi Yee Chu; Maggie S H Cheung; Bei Wang; Yee Man Chan; Silvia Y L Mak; Anskar Y Leung; Gigi C G Choi; Zongli Zheng; Alan S L Wong
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.